Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.
持续低剂量沙利度胺：晚期黑色素瘤、肾细胞癌、卵巢癌和乳腺癌的 II 期研究
期刊:British Journal of Cancer
影响因子:6.8
doi:10.1054/bjoc.1999.1004
Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan M M, Pyle L, Johnston S R, Ahern R, Smith I E, Gore M E
